數位治療市場規模、佔有率、成長分析（按產品、應用、收益模式、銷售管道和地區）—2025 年至 2032 年產業預測

2023 年數位治療市場規模價值 65 億美元，預計將從 2024 年的 82.1 億美元成長到 2032 年的 531.5 億美元，預測期間（2025-2032 年）的複合年成長率為 26.3%。

數位治療市場正在經歷強勁成長，這得益於對提供循證治療性介入的軟體和設備的需求激增。這些技術將幫助醫療保健提供者預防和管理一系列慢性疾病，包括精神健康障礙、糖尿病、呼吸系統疾病和心血管疾病。糖尿病、精神疾病、癌症和心臟衰竭等慢性疾病的盛行率不斷上升，大大推動了市場採用。此外，製藥業對數位療法的採用日益增多，進一步推動了這一勢頭。行業領導者正在優先考慮研發，以創新先進的治療方法並進一步推動產品開發。這些因素共同促進了數位治療市場的成長，擴大了患者的治療選擇。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 專利分析
• 技術分析
• 案例研究

數位治療市場規模（按產品和複合年成長率） (2025-2032)

• 市場概覽
• 軟體/平台
• 程式
• 虛擬實境/遊戲

數位治療市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概覽
• 治療/護理相關應用
  • 糖尿病
  • 中樞神經系統 (CNS) 疾病
  • 精神疾病
  • 其他中樞神經系統疾病
  • 禁止抽煙
  • 慢性呼吸系統疾病
  • 肌肉骨骼疾病
  • 心血管疾病
  • 藥物依從性
  • 胃腸道疾病
  • 復健和患者照護
  • 物質使用疾患與成癮管理
  • 其他治療/護理相關用途
• 預防性使用
  • 糖尿病前期
  • 肥胖
  • 營養
  • 生活方式管理
  • 其他預防應用

數位治療市場規模（按收益模式和複合年成長率） (2025-2032)

• 市場概覽
• 訂閱模式
• 一次性購買/年度授權模式
• 基於結果/價值的模型

數位治療市場規模（按銷售管道和複合年成長率） (2025-2032)

• 市場概覽
• B2B銷售管道
  • 付款人
  • 雇主
  • 製藥公司
  • 提供者
  • 其他買家
• B2C銷售管道
  • 看護者
  • 病人

數位治療市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Dassault Systemes（SIMULIA）（France）
• Siemens Digital Industries Software（Simcenter）（Germany）
• PTC（Creo）（US）
• Autodesk（Simulation）（US）
• OpenFOAM（Open-source）（N/A）
• STAR-CCM+（US/Germany）
• COMSOL Multiphysics（Sweden）
• ESI Group（France）
• MathWorks（MATLAB/Simulink）（US）
• Flow3D（US）
• Cadence Design Systems（US）
• Synopsys（US）
• Pointwise（US）

結論和建議

Digital Therapeutics Market size was valued at USD 6.5 billion in 2023 and is poised to grow from USD 8.21 billion in 2024 to USD 53.15 billion by 2032, growing at a CAGR of 26.3% during the forecast period (2025-2032).

The digital therapeutics market is experiencing robust growth, driven by a surge in demand for software and devices that offer evidence-based therapeutic interventions. These technologies assist healthcare providers in the prevention and management of various chronic diseases, including mental health disorders, diabetes, respiratory conditions, and cardiovascular issues. Rising incidences of chronic illnesses such as diabetes, mental health disorders, cancer, and heart failure are significantly boosting market adoption. Additionally, the pharmaceutical sector's increasing embrace of digital therapeutics is contributing to this momentum. Industry leaders are prioritizing research and development to innovate advanced therapies, further propelling product development. Collectively, these elements are fostering the expansion of the digital therapeutics market and enhancing treatment options for patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Digital Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Digital Therapeutics Market Segments Analysis

Global Digital Therapeutics Market is segmented by Offering, Application, Revenue Model, Sales Channel and region. Based on Offering, the market is segmented into Software/Platforms, Programs and Virtual Reality/Games. Based on Application, the market is segmented into Treatment/Care-Related Applications and Preventive Applications. Based on Revenue Model, the market is segmented into Subscription-Based Model, One-Time Purchase/Annual Licensing Model and Outcome /Value-Based Model. Based on Sales Channel, the market is segmented into B2B Sales Channel and B2C Sales Channel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Digital Therapeutics Market

The Digital Therapeutics market is being significantly driven by the rising demand for software and devices aimed at managing and treating chronic diseases worldwide. With a growing prevalence of chronic conditions, including type 1 and type 2 diabetes, various cancers, Alzheimer's disease, obesity, and gastrointestinal disorders, the need for innovative therapeutic solutions is becoming increasingly critical. This trend is particularly notable in emerging economies, where the demand for effective digital health interventions is surging. As more people seek accessible and efficient management options for these chronic conditions, the digital therapeutics sector is poised for substantial growth throughout the forecast period.

Restraints in the Digital Therapeutics Market

The Digital Therapeutics market, characterized by its innovative software and device-driven products designed to prevent, manage, or treat various medical conditions, faces significant challenges that hinder its growth. Increasing concerns over cybersecurity threaten to impede the widespread adoption of these therapeutics, as patients grow increasingly aware of the potential risks to their personal medical data. Additionally, regulatory uncertainties, complications with reimbursement processes, and unequal access to technology further complicate the landscape, limiting the market's expansion. As these issues continue to unfold, they contribute to a restrained environment for digital therapeutics in the healthcare ecosystem.

Market Trends of the Digital Therapeutics Market

The integration of digital therapeutics with healthcare systems marks a significant trend in the market, reflecting a shift towards more accessible and efficient patient care. By seamlessly connecting digital therapeutic solutions with electronic health records (EHRs) and other healthcare platforms, providers can enhance real-time data access and monitoring capabilities, ultimately facilitating informed clinical decision-making. This integration not only boosts operational efficiencies and patient outcomes but also strengthens data security and standardization in information sharing. As healthcare continues to embrace technology, the demand for digital therapeutics that align with existing healthcare infrastructures is poised to grow, driving innovation and investment in this pivotal sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Patent Analysis
• Technology Analysis
• Case Studies

Global Digital Therapeutics Market Size by Offering & CAGR (2025-2032)

• Market Overview
• Software/Platforms
• Programs
• Virtual Reality/Games

Global Digital Therapeutics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Treatment/Care-Related Applications
  • Diabetes
  • Central Nervous System (CNS) Disorders
  • Mental health disorders
  • Other CNS disorders
  • Smoking Cessation
  • Chronic Respiratory Diseases
  • Musculoskeletal Disorders
  • Cardiovascular Diseases
  • Medication Adherence
  • Gastrointestinal Disorders
  • Rehabilitation & Patient Care
  • Substance Use Disorders & Addiction Management
  • Other Treatment/Care-Related Applications
• Preventive Applications
  • Prediabetes
  • Obesity
  • Nutrition
  • Lifestyle Management
  • Other Preventive Applications

Global Digital Therapeutics Market Size by Revenue Model & CAGR (2025-2032)

• Market Overview
• Subscription-Based Model
• One-Time Purchase/Annual Licensing Model
• Outcome /Value-Based Model

Global Digital Therapeutics Market Size by Sales Channel & CAGR (2025-2032)

• Market Overview
• B2B Sales Channel
  • Payers
  • Employers
  • Pharmaceutical Companies
  • Providers
  • Other Buyers
• B2C Sales Channel
  • Caregivers
  • Patients

Global Digital Therapeutics Market Size & CAGR (2025-2032)

• North America (Offering, Application, Revenue Model, Sales Channel)
  • US
  • Canada
• Europe (Offering, Application, Revenue Model, Sales Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Application, Revenue Model, Sales Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Application, Revenue Model, Sales Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Application, Revenue Model, Sales Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Dassault Systemes (SIMULIA) (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Digital Industries Software (Simcenter) (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTC (Creo) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autodesk (Simulation) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpenFOAM (Open-source) (N/A)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STAR-CCM+ (US/Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COMSOL Multiphysics (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ESI Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MathWorks (MATLAB/Simulink) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flow3D (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadence Design Systems (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synopsys (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pointwise (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations